{"schema_version":"secwatch.filing_event.v1","accession":"0001809519-23-000033","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.573886+00:00","generated_at":"2026-06-08T07:22:53.658179+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GoodRx Q3 revenue $180M; adjusted revenue $190M, net loss $38.5M","bullets":["Revenue of $180.0M, reduced by $10M client contract termination; adjusted revenue $190.0M.","Net loss $38.5M (21.4% margin); adjusted net income $25.5M (13.4% margin).","Adjusted EBITDA $53.5M (28.1% margin); operating cash flow $60.3M.","Over 550K prescribers via Provider Mode; >7M consumers of prescription offerings."],"urls":{"canonical":"https://secwatch.observer/filing/0001809519-23-000033","json":"https://secwatch.observer/filing/0001809519-23-000033.json","markdown":"https://secwatch.observer/filing/0001809519-23-000033.md","text":"https://secwatch.observer/filing/0001809519-23-000033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000180951923000033/0001809519-23-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000180951923000033/gdrx-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T07:22:53.658179+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1696ad583eba83cf378f9ad5fbae09435a82034f","claim":"GoodRx Holdings, Inc. reported financial results for three and nine months ended September 30, 2023.","evidence_excerpt":"On November 9, 2023, GoodRx Holdings, Inc. (the “Company”) announced the Company’s financial results for the three and nine months ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951923000033/0001809519-23-000033-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine months ended September 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}